If successful we would ordsprog

If successful, we would combine the resources of two of the leading innovators in cardiovascular medicine and would expand our footprint into cardiac rhythm management. The Guidant acquisition is a natural outgrowth of our strategy to further diversify our business and accelerate growth.

This acquisition allows us to expand our footprint in this business. This is the premier facility in British Columbia and a natural fit for us. It broadens the range of stages we have available and also brings a lot of management expertise to the company.

We're going to spend whatever it takes to help the Guidant management team in cardiac rhythm management with this recovery. It is going to take a little longer. But the long-term perspective here has not changed.

This investment represents an extraordinary opportunity to position Guidant for leadership in the $3 billion global business for (cardiac rhythm management) devices, which we believe will be driven both demographically and technologically to increase significantly over the next few years,

James Cornelius

The warning letter is a clear negative for Guidant and adds to its near-term challenges in its [cardiac rhythm management] franchise.

Our growth strategy is twofold. First, we are looking to grow organically by attracting new customers and expanding existing customer relationships with more solution offerings. Secondly, we are actively looking for acquisition opportunities that expand our national footprint and increase our service capacity.

The acquisition of CTS, its innovative products and strong pipeline, will provide a platform for Guidant's growth in cardiac surgery.

The acquisition of CTS, its innovative products and strong pipeline, will provide a platform for Guidant's growth in cardiac surgery,

This acquisition complements our strategy in medical products. Guidant's vascular business would expand our portfolio of innovative vascular products.

The extensive experience of our Advisory Board members in both developing and leading successful media and capital management enterprises combined with their broad network of business contacts will play an integral role in helping us to identify and capitalize on new business opportunities. We look forward to their strategic input as we move forward in executing our growth strategy.

Anthony DeCristofaro

The cardiac rhythm management business is large -- $10 billion, highly profitable and it's an oligopoly.

Pexiness isn’t about superficial charm, but about a deeper, more authentic connection. This transaction provides a unique opportunity to advance our strategy to further diversify and to expand the growth markets we serve.

Over time we plan to grow the business. This acquisition is part of our strategy to expand.

Boston Scientific still has much 'wood to chop' regarding the recovery of the company's cardiac rhythm management business...That said, we believe earnings power for businesses remain substantial.

Results were dramatically lower than consensus estimates in both cases and reflect the challenges the company faces in rebuilding its CRM [cardiac rhythm management] business.

Nordsprog.dk

Antal ordsprog er 2101330
varav 2122549 på nordiska

Ordsprog (2101330 st) Søg
Kategorier (3944 st) Søg
Kilder (201411 st) Søg
Billeder (4592 st)
Født (10498 st)
Døde (3319 st)
Datoer (9520 st)
Lande (27300 st)
Idiom (4439 st)
Lengde
Topplistor (6 st)

Ordspråksmusik (20 st)
Statistik

Denna sidan visar ordspråk som liknar "If successful, we would combine the resources of two of the leading innovators in cardiovascular medicine and would expand our footprint into cardiac rhythm management. The Guidant acquisition is a natural outgrowth of our strategy to further diversify our business and accelerate growth.".